ILMN

AVOID

Illumina Inc.

Health Care

3.42

PEGY ratio

Rank #434

Why This Matters

This stock appears overvalued relative to its growth and dividend yield. Modest projected growth of 6.9% annually.

ILMN trades at 23.5x earnings against 6.9% growth (no dividend) (PEGY 3.42). The valuation appears stretched relative to the available growth and income.

~ Growth estimate uses historical CAGR (forward estimates unavailable)

• Growth rate derived from historical CAGR — limited analyst coverage.

Scan date: 2026-04-24

Valuation

23.5x

P/E Ratio

Growth

6.9%

5yr EPS

Income

0.0%

Div Yield

PEGY Components

PEGY Score3.42

Denominator6.9%

EPS (TTM)$5.45

Market Data

Price$127.88

ExchangeNASDAQ

S&P 500Nasdaq 100

What Changed

PEGY Score

3.59→3.42(-0.18)

Rank

#333→#434(101 positions)

vs 7 days ago

Portfolio Context

Founder does not hold this stock.

Not in your portfolio.

Sector: Health Care

PEGY History — 90 days

I Want to Invest Not Right Now

Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only